Targeted Delivery of Geraniol via Hyaluronic Acid-Conjugation Enhances Its Anti-Tumor Activity Against Prostate Cancer.

Han YuNa NingFujin HeJiao XuHan ZhaoShao-Feng DuanYunqi Zhao

Published in: International journal of nanomedicine (2024)

HA-SS-Geraniol holds promise as a biologically safe and potentially effective therapeutic agent for prostate cancer treatment. Its targeted delivery system utilizing HA as a carrier shows potential for improving the efficacy of geraniol in cancer therapy.

Keyphrases

prostate cancer
cancer therapy
hyaluronic acid
drug delivery
radical prostatectomy
benign prostatic hyperplasia
machine learning
risk assessment